Skip to content

Omega-3 supplementation in patients with constant weight-related pain: a clinical trial

Omega-3 supplementation in patients with chronic pain related to obesity: a randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2mqrgk7
Enrollment
Unknown
Registered
2022-10-28
Start date
2022-05-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cronic pain

Interventions

This is a two-arm, double-blind, randomized controlled clinical trial. The experimental group will be 54 individuals consuming 2 g of omega-3, divided into 1 g at lunch and 1 g at dinner and a control

Sponsors

Universidade do Sul de Santa Catarina - Unisul
Lead Sponsor
Universidade do Sul de Santa Catarina - Unisul
Collaborator

Eligibility

Age
20 Years to 59 Years

Inclusion criteria

Inclusion criteria: Volunteer of both sexes; age between 20 and 59 years; diagnosed with obesity grade I and II; at risk of metabolic complications associated with obesity; with obesity-related chronic musculoskeletal pain; and who sign the informed consent

Exclusion criteria

Exclusion criteria: Volunteers using anti-inflammatory drugs (steroidal and non-steroidal) and analgesics; volunteers already taking omega-3 supplementation and volunteers who had corona virus disease 19 during the study will be excluded from the analysis

Design outcomes

Primary

MeasureTime frame
It is expected that there will be a reduction in chronic pain (assessed using the Mcgill questionnaire, pain scale and biochemical parameters) and obesity, using body mass index, waist circumference and percentage of relative body fat and biochemical data) , as well as the improvement in quality of life assessed by the SF-36 quality of life questionnaire after omega-3 supplementation in patients with obesity-related chronic pain. It is intended to contribute with scientific evidence on the benefits of using omega-3 for the treatment of chronic pain in patients with obesity, since being overweight can trigger chronic pain, especially musculoskeletal pain, which can impact the quality of life of these individuals. .

Secondary

MeasureTime frame
It is expected that this research will also contribute to the knowledge of the mechanisms of action of omega-3 supplementation on the modulation of inflammatory mediators such as adiponectin, leptin, tumor necrosis factor, interleukin-6, interleukin-10 and protein C- reactive. It is expected to contribute to the deepening of discussions on the benefits of supplementation with omega-3 to reduce body weight and consequent reduction of pain associated with obesity from the comparison of data obtained before and after intervention.

Countries

Brazil

Contacts

Public ContactFranciane Bobinski

Universidade do Sul de Santa Catarina - Unisul

franciane.bobinski@institutoanimaeducacao.org.br+55-048-32791167

Outcome results

None listed

Source: REBEC (via WHO ICTRP)